Abstract Machine learning (ML) is a burgeoning field of medicine with huge resources being
applied to fuse computer science and statistics to medical problems. Proponents of ML extol …

A large body of published work shows that proton (hydrogen 1 [1H]) magnetic resonance
(MR) spectroscopy has evolved from a research tool into a clinical neuroimaging modality …

An extensive amount of information is currently available to clinical specialists, ranging from
details of clinical symptoms to various types of biochemical data and outputs of imaging …

In contrast to almost all other brain tumors, diffuse gliomas infiltrate extensively in the
neuropil. This growth pattern is a major factor in therapeutic failure. Diffuse infiltrative glioma …

Our understanding of the roles that the amino acids glutamate (Glu) and glutamine (Gln)
play in the mammalian central nervous system has increased rapidly in recent times. Many …

Tumour responses to treatment are still largely assessed from imaging measurements of
reductions in tumour size. However, this can take several weeks to become manifest and in …

The clinical use of in vivo magnetic resonance spectroscopy (MRS) has been limited for a
long time, mainly due to its low sensitivity. However, with the advent of clinical MR systems …

Proton NMR spectroscopy is emerging from translational and preclinical neuroscience
research as an important tool for evidence based diagnosis and therapy monitoring. It …

Background Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo
evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction …

Magnetic resonance spectroscopy (MRS) is one of the non-invasive tools used in the
detection of brain tumors. MRS provides a metabolic profile about the brain. In this profile …